The NOR-FIB Study

NOR-FIB is an international multi-center prospective observational study of the occurrence of AF in patients with cryptogenic stroke / TIA. Patients will be monitored with implantable cardiac monitors (ICMs) for  12 months and blood samples measuring biomarkers in the acute phase and at 12 months follow-up.


The objectives are to assess the incidence of AF detection using ICM (Reveal LINQ®) in patients with cryptogenic stroke or TIA and identify biomarkers that can be used as predictors of incident AF.

CRF

Adresse to CRF

(To submit data please click  the links)

CF 1 a

https://nettskjema.uio.no/answer/75307.html

 

CRF 1 b

https://nettskjema.uio.no/answer/76289.html

 

CRF TTE

https://skjema.uio.no/87144

CRF TEE

https://skjema.uio.no/87150

CRF 2

https://nettskjema.uio.no/answer/75411.html

 

CRF 3

https://nettskjema.uio.no/answer/75375.html

 

CRF 4

https://nettskjema.uio.no/answer/75382.html

 

Nyheter

Page 1 of 13  > >>

May 17, 2018
The Nordic Atrial Fibrillation and Stroke Study -FIB Investigator Meeting on . New data from the pilot study presented by PhD student Anna T. Lambert. Thanks to all the local investigators and collaborators! 
Nov 17, 2017

Det tre første danske sentrene - Rigshospitalet, Bispebjerg og Herlev - er aktivert og klare for inklusjon i NOR-FIB. National koordinator i Danmark er Thomas C. Truelsen på Rigshospitalet i København.